FDA
-
-
-
-
-
-
-
Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development
-
-
-
-
-
-
-
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell Shuttle™ Platform
-
-
-
-
-
-
-
Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
-
-
-
-
-
-
-
Autolus receives European approval for CAR T therapy AUCATZYL
-
-
-
-
-
-
-
Autolus Therapeutics (AUTL) Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with R/R B-ALL
-
-
-
-
-
-
-
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
-
-
-
-
-
-
-
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

